Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Loss of CD73-mediated actin polymerization promotes endometrial tumor progression
Jessica L. Bowser, … , Kenneth Dunner Jr., Russell R. Broaddus
Jessica L. Bowser, … , Kenneth Dunner Jr., Russell R. Broaddus
Published December 7, 2015
Citation Information: J Clin Invest. 2016;126(1):220-238. https://doi.org/10.1172/JCI79380.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 53

Loss of CD73-mediated actin polymerization promotes endometrial tumor progression

  • Text
  • PDF
Abstract

Ecto-5′-nucleotidase (CD73) is central to the generation of extracellular adenosine. Previous studies have highlighted a detrimental role for extracellular adenosine in cancer, as it dampens T cell–mediated immune responses. Here, we determined that, in contrast to other cancers, CD73 is markedly downregulated in poorly differentiated and advanced-stage endometrial carcinoma compared with levels in normal endometrium and low-grade tumors. In murine models, CD73 deficiency led to a loss of endometrial epithelial barrier function, and pharmacological CD73 inhibition increased in vitro migration and invasion of endometrial carcinoma cells. Given that CD73-generated adenosine is central to regulating tissue protection and physiology in normal tissues, we hypothesized that CD73-generated adenosine in endometrial carcinoma induces an innate reflex to protect epithelial integrity. CD73 associated with cell-cell contacts, filopodia, and membrane zippers, indicative of involvement in cell-cell adhesion and actin polymerization–dependent processes. We determined that CD73-generated adenosine induces cortical actin polymerization via adenosine A1 receptor (A1R) induction of a Rho GTPase CDC42–dependent conformational change of the actin-related proteins 2 and 3 (ARP2/3) actin polymerization complex member N-WASP. Cortical F-actin elevation increased membrane E-cadherin, β-catenin, and Na+K+ ATPase. Together, these findings reveal that CD73-generated adenosine promotes epithelial integrity and suggest why loss of CD73 in endometrial cancer allows for tumor progression. Moreover, our data indicate that the role of CD73 in cancer is more complex than previously described.

Authors

Jessica L. Bowser, Michael R. Blackburn, Gregory L. Shipley, Jose G. Molina, Kenneth Dunner Jr., Russell R. Broaddus

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Total
Citations: 3 4 5 4 10 6 6 7 6 6 57
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (57)

Title and authors Publication Year
Adenosinergic Signalling in Cervical Cancer Microenvironment
Iser IC, Bertoni AP, Beckenkamp LR, Consolaro ME, Maria-Engler SS, Wink MR
Expert Reviews in Molecular Medicine 2025
CD73+CD8+ T cells define a subset with anti-tumor potential in DLBCL patients
Zhang L, Cheng R, Fan Z, Liu Y, Huang J, Peng J
Frontiers in Medicine 2025
Construction of a prognostic model for endometrial cancer related to programmed cell death using WGCNA and machine learning algorithms
Pan W, Cheng J, Lin S, Li Q, Liang Y, Li H, Nong X, Nong H
Frontiers in Immunology 2025
The metabolic role of the CD73/adenosine signaling pathway in HTR-8/SVneo cells: A Double-Edged Sword?
Song G, Zhang D, Zhu J, Wang A, Zhou X, Han TL, Zhang H
Heliyon 2024
Comprehensive pan-cancer analysis of CD73: Explore its association with prognosis and tumor immune microenvironment
Chen C, Liu S, Ma Y
Heliyon 2024
CD73 restrains mutant β-catenin oncogenic activity in endometrial carcinomas
Hirsch RM, Premsankar S, Kurnit KC, Chiou LF, Rabjohns EM, Lee HN, Broaddus RR, Vaziri C, Bowser JL
bioRxiv 2024
Identification of B Cell Subpopulations with Pro- and Anti-Tumorigenic Properties in an Immunocompetent Mouse Model of Head and Neck Squamous Cell Carcinoma
Sonntag M, Stanojevic S, Laban S, Schuler PJ, Hoffmann TK, Brunner C
Cells 2024
The adenosinergic machinery in cancer: In-tandem insights from basic mechanisms to therapy
Kang C, Liu L, Wu C, Li L, Jia X, Xie W, Chen S, Wu X, Zheng H, Liu J, Li R, Zeng B
Frontiers in immunology 2023
5ʹ-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells
Shi E, Wu Z, Karaoglan BS, Schwenk-Zieger S, Kranz G, Abdul Razak N, Reichel CA, Canis M, Baumeister P, Zeidler R, Gires O
Journal of biomedical science 2023
A Vaccine against Cancer: Can There Be a Possible Strategy to Face the Challenge? Possible Targets and Paradoxical Effects
Zefferino R, Conese M
Human vaccines 2023
Unraveling the Intricacies of CD73/Adenosine Signaling: The Pulmonary Immune and Stromal Microenvironment in Lung Cancer
Saigí M, Mesía-Carbonell O, Barbie DA, Guillamat-Prats R
Cancers 2023
The inhibitory effect of adenosine on tumor adaptive immunity and intervention strategies
Wang L, Zhang J, Zhang W, Zheng M, Guo H, Pan X, Li W, Yang B, Ding L
Acta pharmaceutica Sinica. B 2023
Tumor Infiltration with CD20+CD73+ B Cells Correlates with Better Outcome in Colorectal Cancer
F Hansen, Z Wu, P David, A Mittelstädt, A Jacobsen, M Podolska, K Ubieta, M Brunner, D Kouhestani, I Swierzy, L Roßdeutsch, B Klösch, I Kutschick, S Merkel, A Denz, K Weber, C Geppert, R Grützmann, A Bénard, G Weber
International journal of molecular sciences 2022
4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR)—A Novel Oncometabolite Modulating Cancer-Endothelial Interactions in Breast Cancer Metastasis
Koszalka P, Kutryb-Zajac B, Mierzejewska P, Tomczyk M, Wietrzyk J, Serafin PK, Smolenski RT, Slominska EM
International journal of molecular sciences 2022
腺苷/A2AR信号通路阻断在肿瘤治疗中的应用
2022
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain
Yegutkin GG, Boison D
Pharmacological reviews 2022
Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability
J Do, D Zwick, JD Kenyon, F Zhong, D Askew, AY Huang, WV Hof, M Finney, MJ Laughlin
Scientific Reports 2021
The elegant complexity of mammalian ecto-5′-nucleotidase (CD73)
KP Alcedo, JL Bowser, NT Snider
Trends in Cell Biology 2021
Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival
J Zhao, L Soto, H Wang, M Katz, L Prakash, M Kim, C Tzeng, J Lee, R Wolff, Y Huang, I Wistuba, A Maitra, H Wang
Pancreatology 2021
Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer
KC Kurnit, A Draisey, RC Kazen, C Chung, LH Phan, JB Harvey, J Feng, SS Xie, RR Broaddus, JL Bowser
Cancer Letters 2021
High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer
Y Bareche, S Pommey, M Carneiro, L Buisseret, I Cousineau, P Thebault, P Chrobak, L Communal, D Allard, SC Robson, AM Mes-Masson, D Provencher, R Lapointe, J Stagg
Journal for ImmunoTherapy of Cancer 2021
Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?
J Kotulová, M Hajdúch, P Džubák
International journal of molecular sciences 2021
Molecular subversion of Cdc42 signalling in cancer
NP Murphy, AM binti Ahmad Mokhtar, HR Mott, D Owen
Biochemical Society Transactions 2021
Characterization of the Endometrial MSC Marker Ectonucleoside Triphosphate Diphosphohydrolase-2 (NTPDase2/CD39L1) in Low- and High-Grade Endometrial Carcinomas: Loss of Stromal Expression in the Invasive Phenotypes
A Rodríguez-Martínez, C Trapero, A Vidal, JM Piulats, IG de Aranda, J Sévigny, ME Fernández-Montolí, J Ponce, X Matias-Guiu, M Martín-Satué
Journal of Personalized Medicine 2021
Loss of stromal CD73 expression plays a role in pathogenesis of polypoid endometriosis
AY Altay, E Yavuz, A Bayram, C Yasa, SE Akhan, S Topuz, S Onder
Archives of Gynecology and Obstetrics 2021
High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL)
JC Pritchett, ZZ Yang, HJ Kim, JC Villasboas, X Tang, S Jalali, JR Cerhan, AL Feldman, SM Ansell
Leukemia 2021
Targeting CD73 to augment cancer immunotherapy
M Roh, DA Wainwright, JD Wu, Y Wan, B Zhang
Current Opinion in Pharmacology 2020
Varied functions of immune checkpoints during cancer metastasis
A Safarzadeh, M Alizadeh, F Beyranvand, RF Jozaaee, K Hajiasgharzadeh, A Baghbanzadeh, A Derakhshani, A Argentiero, B Baradaran, N Silvestris
Cancer Immunology, Immunotherapy 2020
CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
JB Harvey, LH Phan, OE Villarreal, JL Bowser
Frontiers in immunology 2020
The adenosine pathway in immuno-oncology
B Allard, D Allard, L Buisseret, J Stagg
Nature Reviews Clinical Oncology 2020
The yin and yang functions of extracellular ATP and adenosine in tumor immunity
L Feng, Y Cai, M Zhu, L Xing, X Wang
Cancer Cell International 2020
CD73: A Promising Biomarker in Cancer Patients
R Turiello, A Pinto, S Morello
Frontiers in pharmacology 2020
Downregulation of CD73 associates with T cell exhaustion in AML patients
Y Kong, B Jia, C Zhao, DF Claxton, A Sharma, C Annageldiyev, JS Fotos, H Zeng, RF Paulson, KS Prabhu, H Zheng
Journal of Hematology & Oncology 2019
Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors
AM Chambers, S Matosevic
Frontiers in Molecular Biosciences 2019
CD73: an emerging checkpoint for cancer immunotherapy
S Chen, DA Wainwright, JD Wu, Y Wan, DE Matei, Y Zhang, B Zhang
Immunotherapy 2019
Tumor‐Selective Altered Glycosylation and Functional Attenuation of CD73 in Human Hepatocellular Carcinoma
KP Alcedo, A Guerrero, V Basrur, D Fu, ML Richardson, JS McLane, CC Tsou, AI Nesvizhskii, TH Welling, CB Lebrilla, CA Otey, HJ Kim, MB Omary, NT Snider
Hepatology Communications 2019
NT5E is associated with unfavorable prognosis and regulates cell proliferation and motility in gastric cancer
S Hu, F Meng, X Yin, C Cao, G Zhang
Bioscience Reports 2019
Impaired Expression of Ectonucleotidases in Ectopic and Eutopic Endometrial Tissue Is in Favor of ATP Accumulation in the Tissue Microenvironment in Endometriosis
C Trapero, A Vidal, ME Fernández-Montolí, B Coroleu, F Tresserra, P Barri, IG de Aranda, J Sévigny, J Ponce, X Matias-Guiu, M Martín-Satué
International journal of molecular sciences 2019
Adenosinergic signaling as a target for natural killer cell immunotherapy
J Wang, S Matosevic
Journal of Molecular Medicine 2018
The Hypoxia–Adenosine Link during Intestinal Inflammation
JL Bowser, LH Phan, HK Eltzschig
Journal of immunology (Baltimore, Md. : 1950) 2018
Targeting adenosine for cancer immunotherapy
RD Leone, LA Emens
Journal for ImmunoTherapy of Cancer 2018
The expression of the MSC-marker CD73 and of NF2/Merlin are correlated in meningiomas
E Kirches, T Steffen, N Waldt, E Hebert, D Pachow, A Wilisch-Neumann, G Keilhoff, T Schneider, WE Braunsdorf, JP Warnke, C Mawrin
Journal of Neuro-Oncology 2018
Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface
R Rahimova, S Fontanel, C Lionne, LP Jordheim, S Peyrottes, L Chaloin, A Schlessinger
PLoS computational biology 2018
Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association
G Kim, KC Kurnit, B Djordjevic, C Singh, MF Munsell, WL Wang, AJ Lazar, W Zhang, R Broaddus
Modern Pathology 2018
Regnase-1 controls colon epithelial regeneration via regulation of mTOR and purine metabolism
Y Nagahama, M Shimoda, G Mao, SK Singh, Y Kozakai, X Sun, D Motooka, S Nakamura, H Tanaka, T Satoh, K Maeda, S Akira
Proceedings of the National Academy of Sciences 2018
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
B Allard, MS Longhi, SC Robson, J Stagg
Immunological Reviews 2017
The hypoxia-adenosine link during inflammation
JL Bowser, JW Lee, X Yuan, HK Eltzschig
Journal of applied physiology 2017
Targeting immunosuppressive adenosine in cancer
D Vijayan, A Young, MW Teng, MJ Smyth
Nature Reviews Cancer 2017
Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor–Host Interaction and Therapeutic Perspectives
PA Mello, R Coutinho-Silva, LE Savio
Frontiers in immunology 2017
Purinergic Signalling: Therapeutic Developments
G Burnstock
Frontiers in pharmacology 2017
Heme oxygenase 1 governs the cytoskeleton at filopodia: pulling the brakes on the migratory capacity of prostate tumoral cells
A Paez, E Vazquez, G Gueron
Cell Death Discovery 2017
Extracellular purines, purinergic receptors and tumor growth
FD Virgilio, E Adinolfi
Oncogene 2016
Adenosine arrests breast cancer cell motility by A3 receptor stimulation
C Ledderose, MM Hefti, Y Chen, Y Bao, T Seier, L Li, T Woehrle, J Zhang, WG Junger
Purinergic Signalling 2016
MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis
Y Wang, L Hu, P Ji, F Teng, W Tian, Y Liu, D Cogdell, J Liu, AK Sood, R Broaddus, F Xue, W Zhang
Journal of Hematology & Oncology 2016
Heme oxygenase-1 in the forefront of a multi-molecular network that governs cell–cell contacts and filopodia-induced zippering in prostate cancer
AV Paez, C Pallavicini, F Schuster, MP Valacco, J Giudice, EG Ortiz, N Anselmino, E Labanca, M Binaghi, M Salierno, MA Martí, JH Cotignola, A Woloszynska-Read, L Bruno, V Levi, N Navone, ES Vazquez, G Gueron
Cell Death and Disease 2016
CD73s protection of epithelial integrity: Thinking beyond the barrier
JL Bowser, RR Broaddus
Tissue Barriers 2016
MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma
N Bonnin, E Armandy, J Carras, S Ferrandon, P Battiston-Montagne, M Aubry, S Guihard, D Meyronet, JP Foy, P Saintigny, S Ledrappier, A Jung, R Rimokh, C Rodriguez-Lafrasse, D Poncet
Oncotarget 2016

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 7 news outlets
Posted by 3 X users
On 1 Facebook pages
Mentioned in 1 Google+ posts
60 readers on Mendeley
See more details